<DOC>
	<DOC>NCT01189747</DOC>
	<brief_summary>This study will evaluate the safety and efficacy of botulinum toxin Type A compared to placebo for the treatment of Crow's Feet Lines (Lateral Canthal Rhytides).</brief_summary>
	<brief_title>Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines</brief_title>
	<detailed_description />
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Moderate to severe Crow's Feet Lines Have adequate vision without the use of eyeglasses to assess facial wrinkles in a mirror (contact lenses OK) Current or previous botulinum toxin treatment of any serotype Facial laser or light treatment, microdermabrasion or superficial peels within 3 months Oral retinoid therapy within 1 year Prior facial cosmetic surgery (eg, periorbital surgery, facial lift, brow lift, eye lift, or eyebrow surgery) Diagnosis of myasthenia gravis, EatonLambert syndrome, amyotrophic lateral sclerosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>